Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$12,582,000
-$661,401 QoQ
Shares Held
50,000
-17.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#805
of 4,167 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAISSE DES DEPOTS ET CONSIGNATIONS holds $1,021,883,854 across 8 Drug Manufacturers - General names. ABBV ranks #4 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
5,034,088 | $954,563,766 | |
| 2 | JNJ |
Johnson & Johnson
|
58,227 | $14,787,911 | |
| 3 | LLY |
ELI LILLY & Co
|
11,381 | $13,650,713 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
50,000 | $12,582,000 | |
| 5 | MRK |
Merck & Co., Inc.
|
79,080 | $10,161,780 | |
| 6 | PFE |
Pfizer Inc
|
344,210 | $8,288,576 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
57,303 | $7,239,661 | |
| 8 | AMGN |
Amgen Inc
|
1,683 | $609,447 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,582,000 | 50,000 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $13,243,401 | 60,892 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $13,570,249 | 59,391 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $13,751,392 | 59,391 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $11,024,157 | 59,391 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $12,029,590 | 57,415 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $10,560,177 | 59,427 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||